Bitget App
Trade smarter
MarketsTradeFuturesStocksEarnInstitutionAI & More
Morgan Stanley optimistic about AI semiconductor market: TSMC has strong certainty, ACM Research and Silicon Motion Technology have over 50% upside potential in target price

Morgan Stanley optimistic about AI semiconductor market: TSMC has strong certainty, ACM Research and Silicon Motion Technology have over 50% upside potential in target price

智通财经智通财经2026/10/09 14:07
Show original

According to Odaily, in its latest report covering the Greater China semiconductor sector, Morgan Stanley gave the AI semiconductor industry chain an "attractive" sector rating. Among investable US equities, TSMC (TSM.US) was identified by Morgan Stanley as the most certain beneficiary. Together with ACM Research (ACMR.US) and Silicon Motion (SIMO.US), it forms the core portfolio benefiting from the expansion of AI computing power.

According to Jinse Finance APP, in the latest report released by Morgan Stanley covering the Greater China semiconductor sector, the AI semiconductor industry chain was given an "attractive" industry rating. Among investable targets in US stocks, TSMC (TSM.US) is seen by Morgan Stanley as the most certain beneficiary, forming the core beneficiary portfolio of AI computing power expansion together with ACM Research (ACMR.US) and Silicon Motion Technology (SIMO.US).
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

You may also like

U.S. stocks move | Moderna (MRNA.US) rises 7% after being included in the Nasdaq 100 Index

According to information from Zhihui Finance APP, on Friday, Moderna (MRNA.US) surged as much as 10% during trading, reaching its highest share price since December 2022. As of press time, the gain narrowed to 7%, with the stock trading at $210.95. On the news front, on October 9, Moderna was officially included in the Nasdaq 100 index, replacing Warner Bros Discovery. After its inclusion, some broad-based institutions that previously did not allocate to biotech will now passively hold the stock, while active institutions will add the company to their watch lists, increasing attention on the individual stock.

智通财经•2026/10/09 15:56